You are running an unsupported browser, please upgrade your browser. Close

Email Subscription

Never miss the latest news and offers - subscribe now!

Never miss the latest news and offers - subscribe now!

Privacy Policy and Cookies

By browsing this site you accept cookies used to improve and personalize our services and marketing. Learn more about our Data Privacy Policy, including cookies, by clicking the Policy button.

By browsing this site you accept cookies used to improve and personalize our services and marketing. Learn more about our Data Privacy Policy, including cookies, by clicking the Policy button.

chromatography
Biotech

Chromatography

The right tools in hand to maximize success of therapeutic protein and gene therapy production

Decreasing Therapeutic Protein Costs and Improving Process Safety

Chromatography is an essential part of the production of novel recombinant proteins, monoclonal and engineered antibodies, or viral vectors for gene therapy. Market pressure requires manufacturers to speed up development, simplify protein or viral vectors purification processes, and improve process economics. Consistent, scalable and validated purification platform solutions can fast track the purification process from R&D phases up to cGMP large-scale production.

 

There is a strong pressure to decrease therapeutic proteins market cost, and conventional capture chromatography, particularly Protein A chromatography media, can be a significant contributor to this cost. In addition, there is the cost and inconvenience of handling large buffer volumes and large processing hardware typically required for industrial scale protein production. Strategies to reduce cost and make more efficient use of the chromatography hardware and resin suggest running more but smaller batches ideally in a shorter timeframe. This can be achieved by using single-use chromatography equipment and resins, and/or processing chromatography in a continuous mode.

 

Continuous, multi-column chromatography allows the switch from large columns used in batch mode to smaller columns cycled and operated in series. Multi-column chromatography (MCC) offers important productivity benefits and economic gains by using significantly less use of expensive chromatography sorbents (i.e. ProteinA or other affinity) and buffers. MCC also results in smaller footprint for chromatography systems, while processing similar harvest volumes, with as result a significant decrease of protein drug production costs. 

 

Pall has a commitment to the manufacturing of industrial chromatography resins that can be operated in conventional, continuous and/or single-use modes.

 

Chromatography performance can be dramatically increased and costs reduced with the right associated hardware and automation selected. Pall is a leading supplier of chromatography columns, packing skids, and batch and continuous chromatography control hardware.

 

Continuous and/or single-use operation can be restricted to only the chromatography step or extended to the full process, from cell culture to final product, using stainless steel or single-use technologies. Pall’s integrated solutions allow you to select the best pathway for your process needs. 

 

Membrane Chromatography

Single-use chromatography solution to purify viral vectors and remove impurities from therapeutic proteins
Single-use chromatography solution to purify viral vectors and remove impurities from therapeutic proteins
Read more

Chromatography Resins

cGMP grade chromatography resins for use in conventional, continuous and/or single-use modes
cGMP grade chromatography resins for use in conventional, continuous and/or single-use modes
Read more

Chromatography Systems

Robust and Economic Purification Platforms Through the Selection of Optimal Chromatography systems
Robust and Economic Purification Platforms Through the Selection of Optimal Chromatography systems
Read more

Featured Products

Cadence™ BioSMB Process 80 System and Cadence BioSMB Process 350 System
Biotech

Cadence™ BioSMB Process 80 System and Cadence BioSMB Process 350 System

Biotech

On-Demand Webinar: Streamline Your Protein Purification Platform

High capacity capture, along with selective and efficient polishing steps are the main criteria for a robust protein purification platform. 

In this webinar, the benefits of Pall’s chromatography process, which features KANEKA KanCapA♦, Mustang® Q and CMM HyperCel™ sorbents will be presented with a focus on the specificity of CMM HyperCel sorbent versus traditional cation exchangers or other mixed mode resins. This three-step process can be operated without any need for diafiltration or dilution between the chromatography steps. 

The results of our investigation show the versatility of CMM HyperCel sorbent which provides flexibility within the development of a process whilst delivering high yield and purity of mAbs and recombinant proteins.

High capacity capture, along with selective and efficient polishing steps are the main criteria for a robust protein purification platform. 

In this webinar, the benefits of Pall’s chromatography process, which features KANEKA KanCapA♦, Mustang® Q and CMM HyperCel™ sorbents will be presented with a focus on the specificity of CMM HyperCel sorbent versus traditional cation exchangers or other mixed mode resins. This three-step process can be operated without any need for diafiltration or dilution between the chromatography steps. 

The results of our investigation show the versatility of CMM HyperCel sorbent which provides flexibility within the development of a process whilst delivering high yield and purity of mAbs and recombinant proteins.

KANEKA KanCapA♦ 3G Affinity Sorbent - Online Ordering Available in the U.S.
Biotech

KANEKA KanCapA♦ 3G Affinity Sorbent - Online Ordering Available in the U.S.